PSA and beyond: alternative prostate cancer biomarkers.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 97, doi. 10.1007/s13402-016-0268-6
- By:
- Publication type:
- Article
Works matching IS 22113428 AND DT 2016 AND VI 39 AND IP 2
Results: 9
1
2
Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 107, doi. 10.1007/s13402-015-0256-2
- By:
- Publication type:
- Article
3
Down-regulation of osteopontin mediates a novel mechanism underlying the cytostatic activity of TGF-β.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 119, doi. 10.1007/s13402-015-0257-1
- By:
- Publication type:
- Article
4
Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 149, doi. 10.1007/s13402-015-0263-3
- By:
- Publication type:
- Article
5
Altered Lamin A/C splice variant expression as a possible diagnostic marker in breast cancer.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 161, doi. 10.1007/s13402-015-0265-1
- By:
- Publication type:
- Article
6
PDCD2 and NCoR1 as putative tumor suppressors in gastric gastrointestinal stromal tumors.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 129, doi. 10.1007/s13402-015-0258-0
- By:
- Publication type:
- Article
7
Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 187, doi. 10.1007/s13402-015-0259-z
- By:
- Publication type:
- Article
8
Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 175, doi. 10.1007/s13402-015-0261-5
- By:
- Publication type:
- Article
9
MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
- Published in:
- Cellular Oncology (2211-3428), 2016, v. 39, n. 2, p. 139, doi. 10.1007/s13402-015-0262-4
- By:
- Publication type:
- Article